{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:10:10Z","timestamp":1789625410896,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.lfs.2011.02.008","type":"journal-article","created":{"date-parts":[[2011,2,13]],"date-time":"2011-02-13T06:40:23Z","timestamp":1297579223000},"page":"693-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice"],"prefix":"10.1016","volume":"88","author":[{"given":"Masako","family":"Isono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Uematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuo","family":"Akira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves A.","family":"DeClerck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotugu","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Majima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2011.02.008_bb0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1084\/jem.20021408","article-title":"Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth","volume":"197","author":"Amano","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.lfs.2011.02.008_bb0010","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lfs.2011.02.008_bb0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00003086-200112000-00029","article-title":"Cyclooxygenase-2 inhibitor for pain management in osteoid osteoma","volume":"393","author":"Bottner","year":"2001","journal-title":"Clin Orthop Relat Res"},{"issue":"Suppl 1","key":"10.1016\/j.lfs.2011.02.008_bb0020","first-page":"S202","article-title":"Neuropeptides and their receptors: innovative science providing novel therapeutic targets","volume":"147","author":"Brain","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"11","key":"10.1016\/j.lfs.2011.02.008_bb0025","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1359\/jbmr.2001.16.11.2074","volume":"16","author":"Chikazu","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.lfs.2011.02.008_bb0030","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2011.02.008_bb0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.lfs.2011.02.008_bb0040","series-title":"Sleisenger and ordtran's gastrointestinal and liver disease: pathophysiology\/diagnosis\/management","first-page":"343","article-title":"Nonsteroidal anti-inflammatory drugs and gastrointestinal disease","author":"Cryer","year":"1998"},{"key":"10.1016\/j.lfs.2011.02.008_bb0045","first-page":"67","article-title":"Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system","volume":"28","author":"Fosslein","year":"1998","journal-title":"Ann Clin Lab Sci"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2011.02.008_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pain.2003.09.003","article-title":"Anti-hyperalgesic activity of the COX-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat","volume":"107","author":"Fox","year":"2004","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.lfs.2011.02.008_bb0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities","volume":"116","author":"Grosser","year":"2006","journal-title":"J Clin Investig"},{"issue":"5","key":"10.1016\/j.lfs.2011.02.008_bb0060","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2559.1993.tb00163.x","article-title":"Mechanism of pain in osteoid osteomas: an immunohistochemical study","volume":"22","author":"Hasegawa","year":"1993","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.lfs.2011.02.008_bb0065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/74999","article-title":"Mantyh PW.Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord","volume":"6","author":"Honore","year":"2000","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.lfs.2011.02.008_bb0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.biopha.2010.01.017","article-title":"mPGES-1-expressing bone marrow-derived cells enhance tumor growth and angiogenesis in mice","volume":"64","author":"Kamata","year":"2010","journal-title":"Biomed Pharmacother"},{"issue":"32","key":"10.1016\/j.lfs.2011.02.008_bb0075","doi-asserted-by":"crossref","first-page":"33,684","DOI":"10.1074\/jbc.M400199200","article-title":"Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1","volume":"279","author":"Kamei","year":"2004","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.lfs.2011.02.008_bb0080","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1210\/endo.139.7.6085","article-title":"Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro","volume":"139","author":"Lader","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2011.02.008_bb0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1052-5157(18)30351-9","article-title":"Nonsteroidal anti-inflammatory drug gastropathy","volume":"6","author":"Laine","year":"1996","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"10.1016\/j.lfs.2011.02.008_bb0090","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJM199610103351507","article-title":"Pharmacologic treatment of cancer pain","volume":"335","author":"Levy","year":"1996","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.lfs.2011.02.008_bb0095","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.lfs.2011.02.008_bb0100","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1210\/endo.141.6.7518","article-title":"Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro","volume":"141","author":"Li","year":"2000","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.lfs.2011.02.008_bb0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000210778","article-title":"Neurogenic inflammation","volume":"1","author":"Lynn","year":"1988","journal-title":"Skin Pharmacol Skin Physiol"},{"issue":"10","key":"10.1016\/j.lfs.2011.02.008_bb0110","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tips.2003.08.005","article-title":"Prostanoid receptor signaling relevant to tumor growth and angiogenesis","volume":"24","author":"Majima","year":"2003","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.lfs.2011.02.008_bb0115","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/rheumatology\/38.8.714","article-title":"Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients","volume":"38","author":"Manabe","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"13\u201314","key":"10.1016\/j.lfs.2011.02.008_bb0120","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S1567-5769(02)00187-X","article-title":"Role of kinin and prostaglandin in cutaneous thermal nociception","volume":"2","author":"Matsuzaki","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.lfs.2011.02.008_bb0125","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1016\/S0021-9258(18)53294-4","article-title":"Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs","volume":"268","author":"Meade","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2011.02.008_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(96)03267-8","article-title":"Malignant bone pain: pathophysiology and treatment","volume":"69","author":"Mercadante","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2011.02.008_bb0135","first-page":"495","article-title":"Controversies over spinal treatment in advanced cancer patients","volume":"6","author":"Mercadante","year":"1998","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.lfs.2011.02.008_bb0140","doi-asserted-by":"crossref","first-page":"11,693","DOI":"10.1073\/pnas.90.24.11693","article-title":"Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase","volume":"90","author":"Mitchell","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lfs.2011.02.008_bb0145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1477-7525-7-102","article-title":"Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008","volume":"7","author":"Montazeri","year":"2009","journal-title":"Health Qual Life Outcomes"},{"issue":"6643","key":"10.1016\/j.lfs.2011.02.008_bb0150","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/41780","article-title":"Altered pain perception and inflammatory response in mice lacking prostacyclin receptor","volume":"388","author":"Murata","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.lfs.2011.02.008_bb0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.gastro.2007.10.001","article-title":"Roles of calcitonin gene-related peptide in maintenance of gastric mucosal integrity and in enhancement of ulcer healing and angiogenesis","volume":"134","author":"Ohno","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2011.02.008_bb0160","first-page":"25","article-title":"Managing cancer pain poorly responsive to systemic opioid therapy","volume":"13","author":"Portenoy","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.lfs.2011.02.008_bb0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3959(90)90004-W","article-title":"Breakthrough pain: definition, prevalence and characteristics","volume":"41","author":"Portenoy","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2011.02.008_bb0170","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(99)01310-0","article-title":"Management of cancer pain","volume":"353","author":"Portenoy","year":"1999","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.lfs.2011.02.008_bb0175","first-page":"7343","article-title":"Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2","volume":"62","author":"Sabino","year":"2002","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.lfs.2011.02.008_bb0180","doi-asserted-by":"crossref","first-page":"G68","DOI":"10.1152\/ajpgi.00538.2002","article-title":"Mild irritant prevents ethanol-induced gastric mucosal microcirculatory disturbances through actions of calcitonin gene-related peptide and PGI2 in rats","volume":"286","author":"Saeki","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.lfs.2011.02.008_bb0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pr.59.3.1","article-title":"Membrane prostaglandin E synthase-1: a novel therapeutic target","volume":"59","author":"Samuelsson","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.lfs.2011.02.008_bb0190","first-page":"3026","article-title":"Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate1","volume":"63","author":"Sohara","year":"2003","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.lfs.2011.02.008_bb0195","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1172\/JCI6749","article-title":"The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure","volume":"107","author":"Stock","year":"2001","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.lfs.2011.02.008_bb0200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr Rev"},{"issue":"25","key":"10.1016\/j.lfs.2011.02.008_bb0205","doi-asserted-by":"crossref","first-page":"22,199","DOI":"10.1074\/jbc.M303227200","article-title":"Human microsomal prostaglandin E synthase-1: purification, functional characterization, and projection structure determination","volume":"278","author":"Thor\u00e9n","year":"2003","journal-title":"J Biol Chem"},{"issue":"36","key":"10.1016\/j.lfs.2011.02.008_bb0210","doi-asserted-by":"crossref","first-page":"13,550","DOI":"10.1073\/pnas.0800767105","article-title":"Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide","volume":"105","author":"Toda","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.lfs.2011.02.008_bb0215","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/ar431","article-title":"The molecular mechanism of osteoclastogenesis in rheumatoid arthritis","volume":"4","author":"Udagawa","year":"2002","journal-title":"Arthritis Res"},{"issue":"11","key":"10.1016\/j.lfs.2011.02.008_bb0220","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.4049\/jimmunol.168.11.5811","article-title":"Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4\/MyD88\/NF-IL6 pathway","volume":"168","author":"Uematsu","year":"2002","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.lfs.2011.02.008_bb0225","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-2952(01)00654-2","article-title":"Major roles of prostanoid receptors IP and EP(3) in endotoxin-induced enhancement of pain perception","volume":"62","author":"Ueno","year":"2001","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.lfs.2011.02.008_bb0230","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/edrv-17-5-533","article-title":"Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials","volume":"17","author":"Wimalawansa","year":"1996","journal-title":"Endocr Rev"},{"key":"10.1016\/j.lfs.2011.02.008_bb0235","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.lfs.2011.02.008_bb0240","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.neuroscience.2007.11.025","article-title":"Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain","volume":"151","author":"Yamamoto","year":"2008","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.lfs.2011.02.008_bb0245","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/01.LAB.0000090159.53224.B9","article-title":"COX-2\/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo","volume":"83","author":"Yoshida","year":"2003","journal-title":"Lab Investig"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051100083X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051100083X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:09:23Z","timestamp":1758398963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432051100083X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":49,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S002432051100083X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2011.02.008","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2011.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}